Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01235078 · ClinicalTrials.gov registry record
Observation of Intraosseous Vascular Access in the Emergency Department
A clinical trial, sponsored by Vidacare Corporation.
- Completed
- Registry status
- 105
- Enrollment target
NCT01235078: Completed study, sponsored by Vidacare Corporation.
NCT01235078 is a clinical trial that has completed, run by Vidacare Corporation. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01235078 has completed, sponsored by Vidacare Corporation.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of powered intraosseous vascular access (EZ-IO by Vidacare) in the emergency department for patients requiring urgent vascular access. Data collected will be compared to historical data on central venous catheter use in the emergency department. The primary hypothesis is that powered intraosseous vascular access will decrease the amount of time needed to obtain vascular access.
Primary Outcome
Time from opening intraosseous device packaging to initial infusion of drugs or fluids via the intraosseous route.
Interventions
- DEVICE EZ-IO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-07 |
What the finished NCT01235078 record still lists
NCT01235078 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which EZ-IO is the first listed.
NCT01235078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01235078 about?
NCT01235078 is a clinical study titled "Observation of Intraosseous Vascular Access in the Emergency Department". The purpose of this study is to evaluate the use of powered intraosseous vascular access (EZ-IO by Vidacare) in the emergency department for patients requiring urgent vascular access. Data collected will be compared to historical data on central venous catheter use in the emergency department. The p...
What is the current status of trial NCT01235078?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2010-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01235078?
The interventions under investigation include: EZ-IO (DEVICE).
Who is sponsoring clinical trial NCT01235078?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia